1. Home
  2. JSPR vs ARQQ Comparison

JSPR vs ARQQ Comparison

Compare JSPR & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPR
  • ARQQ
  • Stock Information
  • Founded
  • JSPR 2018
  • ARQQ 2017
  • Country
  • JSPR United States
  • ARQQ United Kingdom
  • Employees
  • JSPR N/A
  • ARQQ N/A
  • Industry
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • ARQQ Computer Software: Prepackaged Software
  • Sector
  • JSPR Health Care
  • ARQQ Technology
  • Exchange
  • JSPR Nasdaq
  • ARQQ Nasdaq
  • Market Cap
  • JSPR 321.8M
  • ARQQ 282.1M
  • IPO Year
  • JSPR N/A
  • ARQQ N/A
  • Fundamental
  • Price
  • JSPR $21.03
  • ARQQ $36.88
  • Analyst Decision
  • JSPR Strong Buy
  • ARQQ Strong Buy
  • Analyst Count
  • JSPR 11
  • ARQQ 1
  • Target Price
  • JSPR $73.38
  • ARQQ $27.00
  • AVG Volume (30 Days)
  • JSPR 174.0K
  • ARQQ 1.3M
  • Earning Date
  • JSPR 11-07-2024
  • ARQQ 12-31-2024
  • Dividend Yield
  • JSPR N/A
  • ARQQ N/A
  • EPS Growth
  • JSPR N/A
  • ARQQ N/A
  • EPS
  • JSPR N/A
  • ARQQ N/A
  • Revenue
  • JSPR N/A
  • ARQQ $293,000.00
  • Revenue This Year
  • JSPR N/A
  • ARQQ $3,516.04
  • Revenue Next Year
  • JSPR N/A
  • ARQQ N/A
  • P/E Ratio
  • JSPR N/A
  • ARQQ N/A
  • Revenue Growth
  • JSPR N/A
  • ARQQ N/A
  • 52 Week Low
  • JSPR $5.00
  • ARQQ $3.72
  • 52 Week High
  • JSPR $31.01
  • ARQQ $42.79
  • Technical
  • Relative Strength Index (RSI)
  • JSPR 45.81
  • ARQQ 80.58
  • Support Level
  • JSPR $19.41
  • ARQQ $22.30
  • Resistance Level
  • JSPR $23.11
  • ARQQ $30.99
  • Average True Range (ATR)
  • JSPR 1.83
  • ARQQ 6.52
  • MACD
  • JSPR -0.21
  • ARQQ 0.94
  • Stochastic Oscillator
  • JSPR 24.40
  • ARQQ 77.15

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.

Share on Social Networks: